Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Presurgical models can effectively and affordably screen cancer prevention agents.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Finasteride shows promise for preventing prostate cancer, but more research is needed.

Propylthiouracil treatment can cause hair loss.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Apremilast showed mixed results for treating severe alopecia areata.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Targeting ornithine decarboxylase can help prevent skin cancer.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Prostaglandin helps regenerate hair follicles after radiation damage.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Adalimumab helped control a child's severe eye disease when other treatments failed.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

GnRH treatment can reduce breast cancer cell invasion.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.